ubx: the income statement

MyFinsight

Unity Biotechnology, Inc. (UBX)

For the year ending 2024-12-31, UBX made $5,485K in revenue. -$25,951K in net income. Net profit margin of -473.13%.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

	2024-12-31
Unrealized gain (loss) on marketable debt securities	39
Other expense, net	-265
Research and development	13,006
Impairment of long-lived assets	2,705
General and administrative	15,460
Total operating expenses	31,171
Loss from operations	-31,171
Interest income	1,733
Gain on warrant liability	3,713
Net loss	-25,990
Comprehensive loss	-25,951

Basic eps	-1.54
Diluted eps	-1.54
Basic average shares	16,827,038
Diluted average shares	16,827,038

Unit: Thousand (K) dollars (except for numbers of shares and EPS)